| 靶点: |
IC50: 0.3 nM (FASN) |
| 体内研究: |
IPI-9119 (SC 泵输注;0.5 μL/h;100 mg/mL;持续 28 天) 抑制 CRPC 异种移植小鼠模型的肿瘤生长。 |
| 参考文献: |
1. Giorgia Zadra, et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):631-640. 2. Erin Broph, et al. Abstract 1891: Pharmacological target validation studies of fatty acid synthase in carcinoma using the potent, selective and orally bioavailable inhibitor IPI-9119. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.018 ml |
10.092 ml |
20.184 ml |
| 5 mM |
0.404 ml |
2.018 ml |
4.037 ml |
| 10 mM |
0.202 ml |
1.009 ml |
2.018 ml |
| 50 mM |
0.04 ml |
0.202 ml |
0.404 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |